Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Clin Res Hepatol Gastroenterol. 2024 May 3:102366. doi: 10.1016/j.clinre.2024.102366. Online ahead of print.
NO ABSTRACT
PMID:38705235 | DOI:10.1016/j.clinre.2024.102366
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Abnormal liver steatosis and fibrosis serum biomarker levels among psychiatric inpatients
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Abnormal liver steatosis and fibrosis serum biomarker levels among psychiatric inpatients Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population The Pan Immune Inflammatory Value in Relation to Non-Alcoholic Fatty Liver Disease and Hepatic Fibrosis Resmetirom's Approval: Highlighting the Need for Comprehensive Approaches in NASH Therapeutics Efficacy and Safety of Aldafermin in Non-Alcoholic Steatohepatitis: A systematic review and meta-analysis of randomized controlled trials White Adipose Tissue in Metabolic Associated Fatty Liver Disease Probabilistic Scatter Plots for Visualizing Carbohydrate and Lipid Metabolism States in Non-Alcoholic Fatty Liver Disease Artificial Intelligence Chatbots in Healthcare: Navigating Accuracy, Privacy, and Global Applicability Roflumilast ameliorates GAN diet-induced non-alcoholic fatty liver disease by reducing hepatic steatosis and fibrosis in ob/ob mice The Transition in Terminology: From Non-alcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) to Metabolic-associated Steatotic Liver Disease (MASLD) EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) Resmetirom, the long-awaited first treatment for metabolic dysfunction-associated steatohepatitis and liver fibrosis? Comparative and Predictive Significance of Serum Leptin Levels in Non-alcoholic Fatty Liver Disease Recruitment or activation of mast cells in the liver aggravates the accumulation of fibrosis in carbon tetrachloride-induced liver injury Response to: The Synergism of Public Health Policies and Social Work May Reduce Mortality from Cancer, Liver Disease and Cardiovascular Disease THE GLOBAL EPIDEMIOLOGY OF NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS AMONG PATIENTS WITH TYPE 2 DIABETES Serum miR‑29 is increased in mice with early liver fibrosis Myeloid AMPK signaling restricts fibrosis but is not required for metformin improvements during CDAHFD-induced NASH in mice Progress of mesenchymal stem cells (MSCs) & MSC-Exosomes combined with drugs intervention in liver fibrosis Chronic unpredictable mild stress increases serum aldosterone without affecting corticosterone levels and induces hepatic steatosis and renal injury in young adult male rats Angiocrine signaling in sinusoidal homeostasis and liver diseases Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis Inflammation in alcohol-associated hepatitis: pathogenesis and therapeutic targets Incretin-based investigational therapies for the treatment of MASLD/MASH Increased phosphatidylcholine and its hydroperoxides in serum low-density lipoproteins from patients with non-alcoholic steatohepatitis Increased phosphatidylcholine and its hydroperoxides in serum low-density lipoproteins from patients with non-alcoholic steatohepatitis Author's reply: The importance of professional training to foster the implementation of Artificial Intelligence in the clinical setting of liver diseases Letter to the editor: Relationship between educational attainment and non-alcoholic fatty liver disease: A two-sample Mendelian randomization study The role and mechanism of SUMO modification in liver disease Multiscale 3D genome organization underlies duck fatty liver with no adipose inflammation or serious injury Targeting antioxidant factor Nrf2 by raffinose ameliorates lipid dysmetabolism-induced pyroptosis, inflammation and fibrosis in NAFLD Semaglutide alters gut microbiota and improves NAFLD in db/db mice A model of alcoholic liver disease based on different hepatotoxics leading to liver cancer Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease Vitamin D(3) exacerbates steatosis while calcipotriol inhibits inflammation in non-alcoholic fatty liver disease in Sod1 knockout mice: a comparative study of two forms of vitamin D Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology Androsin alleviates non-alcoholic fatty liver disease by activating autophagy and attenuating de novo lipogenesis Autoantibodies against acetylcholine receptors are increased in archived serum samples from patients with schizophrenia Antipsychotics use in autoimmune encephalitis and multiple sclerosis: Impact on hospitalization duration Chronic exposure to ambient air pollution and the risk of non-alcoholic fatty liver disease: A cross-sectional study in Taiwan and Hong Kong Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barré syndrome Baricitinib treatment in children with COPA syndrome The challenge of artificial intelligence in medical writing and editing Radiation Therapy for the Management of Renal Medullary Carcinoma: A Multi-Case Study Tartaric acid ameliorates experimental non-alcoholic fatty liver disease by activating the AMP-activated protein kinase signaling pathway Tartaric acid ameliorates experimental non-alcoholic fatty liver disease by activating the AMP-activated protein kinase signaling pathway Author's reply: AI in medicine, bridging the chasm between potential and capability Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation Characterizing cognitive heterogeneity in first-episode psychosis Investigating delirium in stroke with an EEG lens: Focal lesions with global impact? Lime-Induced Phytophotodermatitis: A Rash That Requires Explicit Questioning Artificial intelligence in medicine: Ethical, deontological aspects and the impact on the doctor-patient relationship Association of Histopathological and Biochemical Aspects of NAFLD With the Severity of Liver Fibrosis in Individuals With Obesity: Cross-sectional Study A PROTEIN COMPLEX OF LIVER ORIGIN ACTIVATES A PRO-INFLAMMATORY PROGRAM THAT DRIVES HEPATIC AND INTESTINAL INJURY IN ALCOHOL-ASSOCIATED LIVER DISEASE A PROTEIN COMPLEX OF LIVER ORIGIN ACTIVATES A PRO-INFLAMMATORY PROGRAM THAT DRIVES HEPATIC AND INTESTINAL INJURY IN ALCOHOL-ASSOCIATED LIVER DISEASE When Combating Dementia in Patients With Atrial Fibrillation Do Not Forget the Missing Bullet Holes When Combating Dementia in Patients With Atrial Fibrillation Do Not Forget the Missing Bullet Holes When Combating Dementia in Patients With Atrial Fibrillation Do Not Forget the Missing Bullet Holes Letter Re: Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: A systematic review and meta-analysis Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease Patients with Suicidal Ideation for Outpatient Surgery at Freestanding Ambulatory Surgery Centers: How Do We Decide to Proceed or to Postpone? ADHD, sleep, chronotype and health in a large cohort of Dutch nurses Autism spectrum disorder in children and young people with FND
Evidence Blueprint
Abnormal liver steatosis and fibrosis serum biomarker levels among psychiatric inpatients
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Abnormal liver steatosis and fibrosis serum biomarker levels among psychiatric inpatients
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Abnormal liver steatosis and fibrosis serum biomarker levels among psychiatric inpatients Aspirin for Non Alcoholic Fatty Liver Disease: Promising but Inconclusive - A Letter to the editor Metabolism-related signalling pathways involved in the pathogenesis and development of metabolic dysfunction-associated steatotic liver disease Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population Factors Associated with Discordance in the Assessment of Fibrosis Stage between Transient Elastography and Liver Biopsy in NAFLD Patients The Pan Immune Inflammatory Value in Relation to Non-Alcoholic Fatty Liver Disease and Hepatic Fibrosis Resmetirom's Approval: Highlighting the Need for Comprehensive Approaches in NASH Therapeutics Efficacy and Safety of Aldafermin in Non-Alcoholic Steatohepatitis: A systematic review and meta-analysis of randomized controlled trials White Adipose Tissue in Metabolic Associated Fatty Liver Disease Increased Risk of Colorectal Adenomas with Metabolic-Associated Fatty Liver Disease Components Effects of Saroglitazar in the Treatment of Non-alcoholic Fatty Liver Disease or Non-alcoholic Steatohepatitis: A Systematic Review and Meta-analysis Probabilistic Scatter Plots for Visualizing Carbohydrate and Lipid Metabolism States in Non-Alcoholic Fatty Liver Disease Independent and joint association of physical activity and adequate weekday sleep duration with metabolic dysfunction-associated steatotic liver disease Satellite liver transplant centres significantly improve transplant assessment outcomes for patients with chronic liver disease but not hepatocellular carcinoma: a retrospective cohort study Granulocyte Colony Stimulating Factor in decompensated cirrhosis, acute alcoholic hepatitis, and acute-on-chronic liver failure: a comprehensive meta-analysis of randomized controlled trials Artificial Intelligence Chatbots in Healthcare: Navigating Accuracy, Privacy, and Global Applicability Roflumilast ameliorates GAN diet-induced non-alcoholic fatty liver disease by reducing hepatic steatosis and fibrosis in ob/ob mice Corrigendum to "SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease" [J Hepatol 80 (2024) 10-19] The Transition in Terminology: From Non-alcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) to Metabolic-associated Steatotic Liver Disease (MASLD) Compromised very-low density lipoprotein induced polyunsaturated triglyceride accumulation in N-nitrosodiethylamine-induced hepatic steatosis EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) Resmetirom, the long-awaited first treatment for metabolic dysfunction-associated steatohepatitis and liver fibrosis? Comparative and Predictive Significance of Serum Leptin Levels in Non-alcoholic Fatty Liver Disease ALT Poorly Predicts Nonalcoholic Fatty Liver Disease (NAFLD) and Liver Fibrosis as Determined by Vibration-Controlled Transient Elastography in Adult National Health and Nutrition Examination Survey 2017-2018: ALT Poorly Predicts NAFLD and… Recruitment or activation of mast cells in the liver aggravates the accumulation of fibrosis in carbon tetrachloride-induced liver injury Evaluation of Antisense Oligonucleotides Therapy Targeting Hsd17b13 in a Fibrosis Mice Model Response to: The Synergism of Public Health Policies and Social Work May Reduce Mortality from Cancer, Liver Disease and Cardiovascular Disease THE GLOBAL EPIDEMIOLOGY OF NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS AMONG PATIENTS WITH TYPE 2 DIABETES Serum miR‑29 is increased in mice with early liver fibrosis Role of Angiotensin II in Non-Alcoholic Steatosis Development Performance of FibroScan in grading steatosis and fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis ALCOHOLIC FOAMY DEGENERATION, AN ENTITY RESEMBLING ALCOHOL-ASSOCIATED HEPATITIS: DIAGNOSIS, PROGNOSIS AND MOLECULAR PROFILING Myeloid AMPK signaling restricts fibrosis but is not required for metformin improvements during CDAHFD-induced NASH in mice Targeted platelet with hydrogen peroxide responsive behavior for non-alcoholic steatohepatitis detection Progress of mesenchymal stem cells (MSCs) & MSC-Exosomes combined with drugs intervention in liver fibrosis Chronic unpredictable mild stress increases serum aldosterone without affecting corticosterone levels and induces hepatic steatosis and renal injury in young adult male rats Various types of fasting diet and possible benefits in nonalcoholic fatty liver: Mechanism of actions and literature update The protective effect of Enteromorpha prolifera polysaccharide on alcoholic liver injury in C57BL/6 mice Angiocrine signaling in sinusoidal homeostasis and liver diseases Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis A Novel cause of Massive Hepatosplenomegaly with Fibrosis in two children: Transient Infantile Hypertriglyceridemia Inflammation in alcohol-associated hepatitis: pathogenesis and therapeutic targets Incretin-based investigational therapies for the treatment of MASLD/MASH Increased phosphatidylcholine and its hydroperoxides in serum low-density lipoproteins from patients with non-alcoholic steatohepatitis Increased phosphatidylcholine and its hydroperoxides in serum low-density lipoproteins from patients with non-alcoholic steatohepatitis Fibroblast growth factor 19 alters bile acids to induce dysbiosis in mice with alcohol-induced liver disease Fibroblast growth factor 19 alters bile acids to induce dysbiosis in mice with alcohol-induced liver disease Specific targeting of the NRF2/β-TrCP axis promotes beneficial effects in NASH Author's reply: The importance of professional training to foster the implementation of Artificial Intelligence in the clinical setting of liver diseases Imbalance of mitochondrial fusion in peripheral blood mononuclear cells is associated with liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis Letter to the editor: Relationship between educational attainment and non-alcoholic fatty liver disease: A two-sample Mendelian randomization study The role and mechanism of SUMO modification in liver disease Increased frequency of hepatic steatosis and fibrosis in patients with gout detected by transient elastography Diagnostic Performance of Quantitative Ultrasound Parameters in Non-alcoholic Fatty Liver Disease Brain-derived neurotrophic factor levels across psychiatric disorders: A systemic review and network meta-analysis Performance of non-invasive tests for liver fibrosis and resolution after bariatric surgery Multiscale 3D genome organization underlies duck fatty liver with no adipose inflammation or serious injury Targeting antioxidant factor Nrf2 by raffinose ameliorates lipid dysmetabolism-induced pyroptosis, inflammation and fibrosis in NAFLD Corrigendum to "Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy" [Epilepsy Res. (2023) 191 107112] Corrigendum to "Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy" [Epilepsy Res. (2023) 191 107112] Semaglutide alters gut microbiota and improves NAFLD in db/db mice A model of alcoholic liver disease based on different hepatotoxics leading to liver cancer Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease Liver fibrosis in pars cohort study: A large-scale study on the prevalence and correlated factors